Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
This report elaborates the market size, market characteristics, and market growth of the Urokinase industry, and breaks down according to the type, application, and consumption area of Urokinase. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Urokinase in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Urokinase market covered in Chapter 13:
Abbott
United Biotech
NDPHARM
Takeda
Sandoz
PKU High-Tech Huatai Pharmaceutica
Livzon Pharmaceutical Group
JCR Pharmaceuticals
Teva
Liaoning Weixing Pharmaceutical
Bharat Biotech
Microbix Biosystems Inc
Novartis
Tianjin Biochem Pharmaceutical
Taj Pharma
Mylan
Suzhou No.1 Pharmaceutical
Mayne Pharma Inc
Pfizer
Zydus Cadila
Squibb
Emcure

In Chapter 6, on the basis of types, the Urokinase market from 2015 to 2025 is primarily split into:
Urokinase Powder
Urokinase Solution

In Chapter 7, on the basis of applications, the Urokinase market from 2015 to 2025 covers:
Hospital use
Clinic
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:

Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025